Postes actifs de Jens-Peter Volkmer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FORTY SEVEN, INC. | Fondateur | 01/01/2014 | - |
| Corporate Officer/Principal | 01/01/2014 | - | |
48 Bio, Inc.
 48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Directeur Général | - | - |
| Directeur Financier/CFO | - | - |
Historique de carrière de Jens-Peter Volkmer
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
48 Bio, Inc.
48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Health Technology |
- Bourse
- Insiders
- Jens-Peter Volkmer
- Expérience
